These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
364 related items for PubMed ID: 8179341
1. Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine. Friedmann PS, Strickland I, Pirmohamed M, Park BK. Arch Dermatol; 1994 May; 130(5):598-604. PubMed ID: 8179341 [Abstract] [Full Text] [Related]
2. T-cell subsets in drug-induced toxic epidermal necrolysis. Possible pathogenic mechanism induced by CD8-positive T cells. Miyauchi H, Hosokawa H, Akaeda T, Iba H, Asada Y. Arch Dermatol; 1991 Jun; 127(6):851-5. PubMed ID: 2036032 [Abstract] [Full Text] [Related]
4. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum. Caproni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, Schena D, Marzano A, Quaglino P, De Simone C, Parodi A, Barletta E, Fabbri P. Br J Dermatol; 2006 Feb; 154(2):319-24. PubMed ID: 16433803 [Abstract] [Full Text] [Related]
5. Distinguishing between erythema multiforme major and Stevens-Johnson syndrome/toxic epidermal necrolysis immunopathologically. Iwai S, Sueki H, Watanabe H, Sasaki Y, Suzuki T, Iijima M. J Dermatol; 2012 Sep; 39(9):781-6. PubMed ID: 22458564 [Abstract] [Full Text] [Related]
7. In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption. Mizukawa Y, Yamazaki Y, Shiohara T. Br J Dermatol; 2008 Jun; 158(6):1230-8. PubMed ID: 18363767 [Abstract] [Full Text] [Related]